Proteomics of Spatially Identified Tissues in Whole Organs
Proteomics of spatially identified tissues in whole organs is an emerging paradigm in high-resolution, high-throughput proteomics that integrates conventional protein analysis techniques with spatial information acquisition. Its goal is to reveal the spatial distribution patterns, expression states, and functional heterogeneity of proteins at the scale of intact organs. While traditional proteomics can identify thousands of proteins within a sample, it typically relies on homogenized tissue extracts and lacks spatial context, making it difficult to determine protein localization across different tissue regions, cellular subdomains, or specific cell types.
In contrast, proteomics of spatially identified tissues in whole organs overcomes these limitations by combining tissue sectioning, spatially resolved sampling, mass spectrometry imaging, and region-specific protein quantification. These integrated approaches allow for a precise and systematic analysis of protein spatial expression profiles across entire organs or tissues. This emerging strategy holds great promise for applications in organ development research, mapping disease-associated spatial heterogeneity, analyzing the tissue microenvironment, and evaluating spatial drug distribution. Its future advancement will depend on improvements in spatial resolution, increased sample throughput, the refinement of data interpretation models, and the maturation of interdisciplinary research frameworks. Additionally, this technology is expected to accelerate large-scale projects such as the Human Protein Atlas and organ-scale molecular modeling, establishing itself as a foundational pillar in biomedical research.
Compared to conventional proteomics, proteomics of spatially identified tissues in whole organs places a stronger emphasis on the integration of “spatial resolution” and “systems-level analysis.” Its technical workflow typically involves in situ tissue preservation and sectioning, tissue annotation and regional partitioning, region-specific protein extraction and quantitative labeling, followed by mass spectrometry detection and spatial data reconstruction. In practice, tissues are often subdivided into multiple regions or microdomains, with proteomic profiles collected and analyzed independently for each area. The final outcome is a spatially visualized protein distribution map at the organ level. This approach provides not only data on protein types and abundances but also their precise anatomical localization, offering a novel perspective on the molecular basis of physiological structures.
The advancement of proteomics of spatially identified tissues in whole organs also requires robust bioinformatics support. In large-scale sample analyses, researchers must not only process conventional mass spectrometry data but also integrate spatial information, tissue annotations, protein interaction networks, and functional pathways to build comprehensive analytical models. Common data analysis strategies include spatial clustering, regional differential analysis, map reconstruction, and co-expression network analysis. These methods aim to preserve spatial resolution while enhancing the depth of functional interpretation. Medical proteomics plays a pivotal role in this context by focusing not only on protein identification but also on functional states, post-translational modifications, and network dynamics. This complements spatial proteomics, offering an integrated view of local physiological and pathological conditions.
Proteomics of spatially identified tissues in whole organs is not a standalone technology but rather an essential component of modern multi-omics integration. Increasingly, researchers are combining it with spatial transcriptomics, single-cell omics, and metabolomics to construct unified spatial-functional molecular maps. For example, comparing mRNA and protein abundances within the same anatomical region can reveal post-transcriptional regulation, while integrating spatial metabolomic maps can help identify protein drivers of localized metabolic remodeling.
MtoZ Biolabs provides high-quality proteomics services that combine spatial resolution with functional insight through systematic project design, meticulous experimental execution, and rigorous data analysis. We support researchers in uncovering spatial mechanisms of disease and mapping spatial expression patterns of biomarkers.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
